台灣泌尿科醫學會E-School

台灣泌尿科醫學會E-School

NDP002: Endovascular treatment for mycotic pseudoaneurysm in a renal transplant patient: A case report

2024-12-20 • 觀看: 512 • 回應: 0 • doc
NDP001: 45,X/46,XY mosaicism male: rare case report and literature review

2024-12-20 • 觀看: 580 • 回應: 0 • doc
MP02-07: Decade of Experience with Adrenalectomy for Adrenal Neoplasms: Clinical Insights and Outcomes

2024-12-20 • 觀看: 524 • 回應: 0 • doc
MP02-06: The Comparison of Maintenance and Induction Intravesical Chemotherapy in the Treatment of Non-Muscle Invasive Bladder Cancer

2024-12-20 • 觀看: 520 • 回應: 0 • doc
MP02-05: High Tumor Mutational Burden as a Predictive Biomarker for Pembrolizumab Efficacy in Metastatic Castration-Resistant Prostate Cancer: A Case Report and Literature Review

2024-12-20 • 觀看: 527 • 回應: 0 • doc
MP02-04: Can pyuria predict Upper tract urothelial carcinoma bladder recurrence ?

2024-12-20 • 觀看: 506 • 回應: 0 • doc
MP02-03: Comparison of Bladder Cuff Excision Method in UTUC

2024-12-20 • 觀看: 509 • 回應: 0 • doc
MP02-02: The ADAMTS1–VCAN–EGFR axis contributes oncogenecity with invasion and anoikis resistance in renal cell carcinoma

2024-12-20 • 觀看: 507 • 回應: 0 • doc
MP01-09: Use of clinical characteristics, cystoscopic findings, and urine biomarkers in predicting satisfactory treatment outcome in women with interstitial cystitis/ bladder pain syndrome

2024-12-20 • 觀看: 529 • 回應: 0 • doc
MP01-08: Cystoscopic hydrodistention characteristics provide clinical and long-term prognostic features of interstitial cystitis after treatment

2024-12-20 • 觀看: 778 • 回應: 0 • doc
MP01-07: Therapeutic efficacy of intensive multimodal therapy for patients with interstitial cystitis/bladder pain syndrome

2024-12-20 • 觀看: 538 • 回應: 0 • doc
MP01-06: Assessing Multiple Versions of ChatGPT in the Taiwan Urology Board Exam: Accuracy, Speed, and Specific Domain Challenges

2024-12-20 • 觀看: 513 • 回應: 0 • doc

Prev
127
128
129
130
131
132
133
134
135
136
Next
/ 1134